Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
今後の臨床試験
-
NCT04308590採用条件：高コルチゾール症
-
NCT02912559採用条件：Colon Adenocarcinoma, DNA修復障害, リンチ症候群, III期の結腸がんAJCCv7, IIIA期の結腸がんAJCCv7, IIIB期の結腸がんAJCCv7, IIIC期の結腸がんAJCCv7
-
NCT04434937採用条件：リンパ腫
-
NCT03711032採用条件：高リスクの非乳房性アルゴリズム
-
NCT04927442採用条件：COVID-19ウイルス病
-
NCT04530110採用条件：片頭痛
-
NCT04438538採用条件：メニエール病
-
NCT03783143まだ募集していない条件：ラッサウイルス感染
-
NCT00646022採用条件：カルチノイド
-
NCT04529772採用条件：びまん性大細胞型B細胞リンパ腫
Recent CRA jobs
-
Senior Regulatory Affairs Consultant - CMC (UK)
-
Senior Consultant - Regulatory Affairs (Poland)
-
Associate, Health Economics Modeling & Simulation (UK/EU based)
-
Associate Director Solution Owner, IDEO
-
Scientific Data Solutions Architect, Director
-
Associate consultant,Health Economics and Outcomes Research
-
Senior Clinical Research Associate (Poland)
-
Senior Associate, Health Economics Modeling (UK/EU locations)
-
Biorepository Lab Services Supervisor (2nd Shift)
-
GP Sales Representative